Using failure mode and effects analysis to improve the safety of neonatal parenteral nutrition

被引:34
作者
Arenas Villafranca, Jose Javier [1 ]
Gomez Sanchez, Araceli [1 ]
Nieto Guindo, Miriam [1 ]
Faus Felipe, Vicente [1 ]
机构
[1] Costa del Sol Hosp, Serv Pharm, Marbella, Malaga, Spain
关键词
EMERGENCY-DEPARTMENT; MEDICATION ERRORS; DRUG; COMMUNICATION;
D O I
10.2146/ajhp130640
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Failure mode and effects analysis (FMEA) was used to identify potential errors and to enable the implementation of measures to improve the safety of neonatal parenteral nutrition (PN). Methods. FMEA was used to analyze the preparation and dispensing of neonatal PN from the perspective of the pharmacy service in a general hospital. A process diagram was drafted, illustrating the different phases of the neonatal PN process. Next, the failures that could occur in each of these phases were compiled and cataloged, and a questionnaire was developed in which respondents were asked to rate the following aspects of each error: incidence, detectability, and severity. The highest scoring failures were considered high risk and identified as priority areas for improvements to be made, Results. The evaluation process detected a total of 82 possible failures. Among the phases with the highest number of possible errors were transcription of the medical order, formulation of the PN, and preparation of material for the formulation. After the classification of these 82 possible failures and of their relative importance, a checklist was developed to achieve greater control in the error-detection process. FMEA demonstrated that use of the checklist reduced the level of risk and improved the detectability of errors. Conclusion. FMEA was useful for detecting medication errors in the PN preparation process and enabling corrective measures to be taken. A checklist was developed to reduce errors in the most critical aspects of the process.
引用
收藏
页码:1210 / 1218
页数:9
相关论文
共 27 条
[1]   Use of failure mode and effects analysis in improving the safety of iv drug administration [J].
Adachi, W ;
Lodolce, AE .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (09) :917-920
[2]   Design of a safer approach to intravenous drug infusions: failure mode effects analysis [J].
Apkon, M ;
Leonard, J ;
Probst, L ;
DeLizio, L ;
Vitale, R .
QUALITY & SAFETY IN HEALTH CARE, 2004, 13 (04) :265-271
[3]   Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions [J].
Bonnabry, P ;
Cingria, L ;
Sadeghipour, F ;
Ing, H ;
Fonzo-Christe, C ;
Pfister, RE .
QUALITY & SAFETY IN HEALTH CARE, 2005, 14 (02) :93-98
[4]  
Burgmeier Jean, 2002, Jt Comm J Qual Improv, V28, P331
[5]   Assessment of drug-related problems in clinical nutrition patients [J].
Cerulli, J ;
Malone, M .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1999, 23 (04) :218-221
[6]   FMEA: A model for reducing medical errors [J].
Chiozza, Maria Laura ;
Ponzetti, Clemente .
CLINICA CHIMICA ACTA, 2009, 404 (01) :75-78
[7]  
Cohen M.R., 2007, Medication errors, V2nd, P317
[8]  
DeRosier Joseph, 2002, Jt Comm J Qual Improv, V28, P248
[9]   Observational study of accuracy in compounding i.v. admixtures at five hospitals [J].
Flynn, EA ;
Pearson, RE ;
Barker, KN .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (08) :904-912
[10]  
Heyland DK, 2001, CAN J SURG, V44, P102